Nanovectors for Diverse Applications
Legal Citation
Summary of the Inventive Concept
Expanding the capabilities of nanovectors beyond biomedical applications to address pressing issues in counterfeit detection, food quality, wastewater treatment, crop yields, and animal disease diagnosis.
Background and Problem Solved
The original patent focused on nanovectors for delivering active substances in the human body. However, the technology's potential extends far beyond biomedical applications. The new inventive concept addresses the limitations of the original patent by exploring novel uses for nanovectors in various industries, tackling specific problems such as counterfeit products, food spoilage, environmental pollution, and animal health.
Detailed Description of the Inventive Concept
The new inventive concept leverages the core technology of polysiloxane-based nanoparticles to develop innovative solutions for diverse industries. For instance, nanovectors can be designed to deliver fluorescent molecules for authentication purposes in counterfeit detection. In food quality monitoring, nanovectors can release antimicrobial peptides to extend shelf life. In wastewater treatment, nanovectors can remove heavy metal ions. In agriculture, nanovectors can deliver plant growth promoters to enhance crop yields. Finally, in animal disease diagnosis, nanovectors can deliver contrast agents for imaging.
Novelty and Inventive Step
The new claims introduce a significant departure from the original patent by applying the nanovector technology to entirely new fields, demonstrating a non-obvious and innovative expansion of the core concept.
Alternative Embodiments and Variations
Other potential implementations of the inventive concept could include using different types of nanoparticles, varying the surface chemistry, or exploring alternative delivery mechanisms. These variations would ensure broad conceptual coverage and adaptability to diverse industry needs.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including security and authentication, food safety, environmental remediation, agriculture, and veterinary medicine. The market for these applications is substantial, with potential customers including government agencies, food manufacturers, wastewater treatment plants, agricultural companies, and veterinary clinics.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K38/31 |
| A | A61 | A61K9/146 |
| A | A61 | A61K31/704 |
| A | A61 | A61K33/243 |
| A | A61 | A61K33/244 |
| A | A61 | A61K47/6929 |
| A | A61 | A61K49/0002 |
| A | A61 | A61K49/128 |
| A | A61 | A61K49/1881 |
| A | A61 | A61P35/00 |
| B | B82 | B82Y5/00 |
| A | A61 | A61K9/0019 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Nanomedicine and materials science, specifically nanoparticle design for targeted delivery systems, with expertise in polysiloxane-based nanoparticle synthesis, surface modification, and multi-domain applications
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degree in chemistry, materials science, or bioengineering, possessing knowledge of nanoparticle functionalization, surface chemistry, and interdisciplinary applications of nanomaterials
Obviousness Rationale
A PHOSITA would recognize the inherent versatility of polysiloxane-based nanoparticles as a fundamental delivery platform that can be readily adapted across multiple domains by modifying surface chemistry and payload. The source patent establishes core nanoparticle design principles that can be systematically extended to new application contexts through predictable surface modifications and targeted molecular attachments. The disclosed variations represent logical, incremental expansions of the fundamental nanovector technology using standard nanomaterial engineering techniques.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,604 |
|---|---|
| Title | Nanovectors and uses |
| Assignee(s) | NH THERAGUIX |